WuXi Biologics and Toregem BioPharma Sign Memorandum of Understanding to Develop…
SHANGHAI, October 11, 2022 /PRNewswire/ — WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global contract research, development and manufacturing company (CRDMO), and Toregem BioPharma, a